HEMOLYTIC-UREMIC SYNDROME
Clinical trials for HEMOLYTIC-UREMIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new HEMOLYTIC-UREMIC SYNDROME trials appear
Sign up with your email to follow new studies for HEMOLYTIC-UREMIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Antibiotic-Free treatment aims to save kidneys in children with e. coli complications
Disease control Recruiting nowThis study tests a new medicine called INM004 in 220 children aged 9 months to 18 years who have a severe kidney condition called hemolytic uremic syndrome (HUS) caused by certain E. coli bacteria. The treatment is an antibody that targets the toxin made by the bacteria, with the…
Matched conditions: HEMOLYTIC-UREMIC SYNDROME
Phase: PHASE3 • Sponsor: Inmunova S.A. • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
New test could unlock precision treatment for deadly clotting disease
Diagnosis Recruiting nowThis study aims to improve how doctors diagnose a rare, life-threatening condition called thrombotic microangiopathy (TMA), which causes blood clots in small vessels and can damage the kidneys and brain. Researchers are testing a new blood test (the HMEC test) to better identify …
Matched conditions: HEMOLYTIC-UREMIC SYNDROME
Sponsor: Maastricht University Medical Center • Aim: Diagnosis
Last updated May 17, 2026 04:50 UTC